2. Apoptosis
  3. RIP kinase Necroptosis
  4. RI-962

RI-962 is a potent and selective receptor-interacting protein kinase 1 (RIPK1) inhibitor. RI-962 inhibits RIPK1 with an IC50 value of 35.0 nM. RI-962 can be used for the research of nervous system diseases and inflammatory diseases.

For research use only. We do not sell to patients.

RI-962 Chemical Structure

RI-962 Chemical Structure

CAS No. : 2763831-53-2

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

RI-962 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

RI-962 is a potent and selective receptor-interacting protein kinase 1 (RIPK1) inhibitor. RI-962 inhibits RIPK1 with an IC50 value of 35.0 nM. RI-962 can be used for the research of nervous system diseases and inflammatory diseases[1].

IC50 & Target

IC50: 35.0 nM (RIPK1); EC50: 10.0 nM (HT29 cells), 4.2 nM (L929 cells), 11.4 nM (J774A.1 cells), 17.8 nM (U937 cells)[1].
In Vitro

RI-962 has potent inhibitory activity for RIPK1 with an IC50 value of 35.0 nM[1].
RI-962 has protective effect for necroptotic death with EC50 values of 10.0 nM, 4.2 nM, 11.4 nM, and 17.8 nM for HT29, L929, J774A.1, and U937 cells, respectively[1].
RI-962 (0-100 μM; 24 h) protectes cells from TSZ-induced necroptosis by inhibiting the kinase activity of RIPK1[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

RI-962 Related Antibodies

Cell Viability Assay[1]

Cell Line: HT29, L929, J774A.1, and U937 cells
Concentration: 0-100 μM
Incubation Time: 24 h
Result: Exerted a dose-dependent protective effect against necroptotic death.

Western Blot Analysis[1]

Cell Line: HT29 cells
Concentration: 0-400 nM
Incubation Time:
Result: Markedly inhibited the phosphorylation of RIPK1 and its downstream signaling proteins RIPK3 and MLKL in a dose-dependent manner.
In Vivo

RI-962 (i.p.; 40 mg/kg; once a day for 10 day) ameliorates TNFα-induced SIRS and reduces inflammation in acute DSS-induced colitis[1].
Pharmacokinetic Parameters of RI-962 in rats (i.v., i.p., p.o.; 5, 20 mg/kg) [1].

RI-962 i.v. p.o. i.p.
Dose (mg/kg) 5 20 20
T1/2 (h) 2.1 ± 0.2 1.3 ± 0.2 8.5 ± 1.6
Tmax (h) 0.1 ± 0.0 0.8 ± 1.0 0.5 ± 0.0
Cmax (ng/mL) 12170.4 ± 1198.5 674.2 ± 424.7 3603.3 ± 693.3
AUC0–t(ng*h/mL) 4526.1 ± 546.0 1594.9 ± 891.8 6459.7 ± 1131.6
AUC0–∞ (ng*h/mL) 4538.1 ± 546.3 1604.5 ± 896.1 6609.3 ± 1121.4
Vss (L/kg) 0.4 ± 0.1 - -
MRT0–∞ (h) 0.4 ± 0.0 1.8 ± 0.2 2.8 ± 0.1
CL (mL/min/kg) 18.5 ± 2.1 - -
F (%) - 8.8 ± 5.0 35.7 ± 6.3

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 female mice[1]
Dosage: 40 mg/kg
Administration: Intraperitoneal for 15 min; once a day for 10 day
Result: Ameliorated TNFα-induced SIRS by inhibiting RIPK1 activity.
Suppressed the RIPK1 signaling in the mouse model of DSS-induced colitis.
Animal Model: Sprague-Dawley (SD) rats[1]
Dosage: 5, 20 mg/kg
Administration: intravenous (i.v.) (5 mg/kg), intraperitoneal (i.p.) (20 mg/kg) and oral (p.o.) (20 mg/kg)
Result: Had good metabolic stability in rats.
Molecular Weight

480.56

Formula

C28H28N6O2
CAS No.
SMILES

O=C(C1=CN(C)C2=C1C=C(C3=CC4=NC(NC(C(C)C)=O)=NN4C=C3)C=C2)NC(C)C5=CC=CC=C5
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

RI-962 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

RI-9622763831-53-2RI962RI 962RIP kinaseNecroptosisReceptor-interacting protein kinasesRIPKkinasesreceptor-interacting protein kinase 1 (RIPK1)nervous system diseasesinflammatory diseasesInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
RI-962
Cat. No.:
HY-148382
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.